A carregar...

Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis

The current Multiple Sclerosis (MS) therapeutic landscape is rapidly growing. Glatiramer acetate (GA) remains unique given its non-immunosuppressive mechanism of action as well as its superior long-term safety and sustained efficacy data. In this review, we discuss proposed mechanisms of action of G...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Aaron Boster, Mary Pat Bartoszek, Colleen O’Connell, David Pitt, Michael Racke
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publishing 2011-09-01
Colecção:Therapeutic Advances in Neurological Disorders
Acesso em linha:https://doi.org/10.1177/1756285611422108
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!